Article

Biosimilars and implications for pharmacy practice: Ready or not, here they come!

Andrea L. Hobbs1★, Joshua P. Crawford2★ Corresponding author

  1. 1PharmD, Transitions of Care Clinical Specialist and Pharmacy Residency Coordinator, Bon Secours Memorial Regional Medical Center, Mechanicsville, VA, United States.
  2. 2PharmD, BCPS, System Director Clinical Pharmacy Services, Bon Secours Mercy Health, Cincinnati, OH, United States.

CORRESPONDENCE

Andrea L. Hobbs

PharmD, Transitions of Care Clinical Specialist and Pharmacy Residency Coordinator, Bon Secours Memorial Regional Medical Center, Mechanicsville, VA, United States.

Andrea_Hobbs@bshsi.org

Received: 19-08-2019; Accepted: 26-08-2019.

Volume 17, Issue 3 · pp. 1659 · PUBLISHED 29 August 2019 · DOI: 10.18549/PharmPract.2019.3.1659

View on PP original site ↗

ABSTRACT

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Hobbs, A. L., & Crawford, J. P. (2019). Biosimilars and implications for pharmacy practice: Ready or not, here they come!. Pharmacy Practice, 17(3), 1659. https://doi.org/10.18549/PharmPract.2019.3.1659